 | • レポートコード：MRC2012A4121 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、泌尿生殖器-泌尿生殖器の世界市場を広く調査・分析し、今後の市場展望をまとめております。泌尿生殖器-泌尿生殖器の種類別市場規模（OTC、処方薬）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Daiichi Sankyo Company、Sanofi、Astellas Pharma、Pfizer、Otsuka Pharmaceutical、Bayer、GSK、Allergan、 ・地域別グローバル市場分析 2015年-2020年 ・泌尿生殖器-泌尿生殖器の北米市場（アメリカ、カナダ、メキシコ） ・泌尿生殖器-泌尿生殖器のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・泌尿生殖器-泌尿生殖器のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・泌尿生殖器-泌尿生殖器の南米市場（ブラジル、アルゼンチン） ・泌尿生殖器-泌尿生殖器の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：OTC、処方薬 ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Genito-Urinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Genito-Urinary Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Genito-Urinary Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Genito-Urinary Drugs market has been segmented into
OTC
Rx Drugs
By Application, Genito-Urinary Drugs has been segmented into:
Hospital
Drugs Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Genito-Urinary Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Genito-Urinary Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genito-Urinary Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Genito-Urinary Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Genito-Urinary Drugs Market Share Analysis
Genito-Urinary Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genito-Urinary Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genito-Urinary Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Genito-Urinary Drugs are:
Daiichi Sankyo Company
Sanofi
Astellas Pharma
Pfizer
Otsuka Pharmaceutical
Bayer
GSK
Allergan
Among other players domestic and global, Genito-Urinary Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Genito-Urinary Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Genito-Urinary Drugs, with price, sales, revenue and global market share of Genito-Urinary Drugs in 2018 and 2019.
Chapter 3, the Genito-Urinary Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Genito-Urinary Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Genito-Urinary Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Genito-Urinary Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Genito-Urinary Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Genito-Urinary Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Genito-Urinary Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Overview of Global Genito-Urinary Drugs Market
1.4.1 Global Genito-Urinary Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Daiichi Sankyo Company SWOT Analysis
2.1.4 Daiichi Sankyo Company Product and Services
2.1.5 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astellas Pharma SWOT Analysis
2.3.4 Astellas Pharma Product and Services
2.3.5 Astellas Pharma Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Otsuka Pharmaceutical
2.5.1 Otsuka Pharmaceutical Details
2.5.2 Otsuka Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Otsuka Pharmaceutical SWOT Analysis
2.5.4 Otsuka Pharmaceutical Product and Services
2.5.5 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allergan SWOT Analysis
2.8.4 Allergan Product and Services
2.8.5 Allergan Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Genito-Urinary Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Genito-Urinary Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Genito-Urinary Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Genito-Urinary Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Genito-Urinary Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Genito-Urinary Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Genito-Urinary Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
4.5 South America Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Genito-Urinary Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Genito-Urinary Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Genito-Urinary Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Genito-Urinary Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Genito-Urinary Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Genito-Urinary Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
6.3 UK Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
6.4 France Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Genito-Urinary Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Genito-Urinary Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Genito-Urinary Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
7.5 India Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Genito-Urinary Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Genito-Urinary Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Genito-Urinary Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Genito-Urinary Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Genito-Urinary Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Genito-Urinary Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Genito-Urinary Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Genito-Urinary Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Genito-Urinary Drugs Price by Type (2015-2020)
11 Global Genito-Urinary Drugs Market Segment by Application
11.1 Global Genito-Urinary Drugs Sales Market Share by Application (2015-2020)
11.2 Global Genito-Urinary Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Genito-Urinary Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Genito-Urinary Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Genito-Urinary Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Genito-Urinary Drugs Market Forecast (2021-2025)
12.2.2 Europe Genito-Urinary Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Genito-Urinary Drugs Market Forecast (2021-2025)
12.2.4 South America Genito-Urinary Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Genito-Urinary Drugs Market Forecast (2021-2025)
12.3 Genito-Urinary Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Genito-Urinary Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Genito-Urinary Drugs Market Share Forecast by Type (2021-2025)
12.4 Genito-Urinary Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Genito-Urinary Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Genito-Urinary Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Genito-Urinary Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Genito-Urinary Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Genito-Urinary Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Company Genito-Urinary Drugs Major Business
Table 9. Daiichi Sankyo Company Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Daiichi Sankyo Company SWOT Analysis
Table 11. Daiichi Sankyo Company Genito-Urinary Drugs Product and Services
Table 12. Daiichi Sankyo Company Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Genito-Urinary Drugs Major Business
Table 15. Sanofi Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Genito-Urinary Drugs Product and Services
Table 18. Sanofi Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Astellas Pharma Genito-Urinary Drugs Major Business
Table 21. Astellas Pharma Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Astellas Pharma SWOT Analysis
Table 23. Astellas Pharma Genito-Urinary Drugs Product and Services
Table 24. Astellas Pharma Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Genito-Urinary Drugs Major Business
Table 27. Pfizer Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Genito-Urinary Drugs Product and Services
Table 30. Pfizer Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Otsuka Pharmaceutical Genito-Urinary Drugs Major Business
Table 33. Otsuka Pharmaceutical Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Otsuka Pharmaceutical SWOT Analysis
Table 35. Otsuka Pharmaceutical Genito-Urinary Drugs Product and Services
Table 36. Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bayer Basic Information, Manufacturing Base and Competitors
Table 38. Bayer Genito-Urinary Drugs Major Business
Table 39. Bayer Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Bayer SWOT Analysis
Table 41. Bayer Genito-Urinary Drugs Product and Services
Table 42. Bayer Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK Genito-Urinary Drugs Major Business
Table 45. GSK Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK Genito-Urinary Drugs Product and Services
Table 48. GSK Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Allergan Basic Information, Manufacturing Base and Competitors
Table 50. Allergan Genito-Urinary Drugs Major Business
Table 51. Allergan Genito-Urinary Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Allergan SWOT Analysis
Table 53. Allergan Genito-Urinary Drugs Product and Services
Table 54. Allergan Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Genito-Urinary Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Genito-Urinary Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Genito-Urinary Drugs Sales by Regions (2015-2020) (K Units)
Table 58. Global Genito-Urinary Drugs Sales Market Share by Regions (2015-2020)
Table 59. Global Genito-Urinary Drugs Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Genito-Urinary Drugs Sales by Countries (2015-2020) (K Units)
Table 61. North America Genito-Urinary Drugs Sales Market Share by Countries (2015-2020)
Table 62. North America Genito-Urinary Drugs Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Genito-Urinary Drugs Revenue Market Share by Countries (2015-2020)
Table 64. Europe Genito-Urinary Drugs Sales by Countries (2015-2020) (K Units)
Table 65. Europe Genito-Urinary Drugs Sales Market Share by Countries (2015-2020)
Table 66. Europe Genito-Urinary Drugs Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Genito-Urinary Drugs Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Genito-Urinary Drugs Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Genito-Urinary Drugs Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Genito-Urinary Drugs Sales by Countries (2015-2020) (K Units)
Table 71. South America Genito-Urinary Drugs Sales Market Share by Countries (2015-2020)
Table 72. South America Genito-Urinary Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Genito-Urinary Drugs Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Genito-Urinary Drugs Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Genito-Urinary Drugs Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Genito-Urinary Drugs Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Genito-Urinary Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Global Genito-Urinary Drugs Sales by Type (2015-2020) (K Units)
Table 79. Global Genito-Urinary Drugs Sales Share by Type (2015-2020)
Table 80. Global Genito-Urinary Drugs Revenue by Type (2015-2020) (USD Million)
Table 81. Global Genito-Urinary Drugs Revenue Share by Type (2015-2020)
Table 82. Global Genito-Urinary Drugs Sales by Application (2015-2020) (K Units)
Table 83. Global Genito-Urinary Drugs Sales Share by Application (2015-2020)
Table 84. Global Genito-Urinary Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Genito-Urinary Drugs Market Share Forecast by Regions (2021-2025)
Table 86. Global Genito-Urinary Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Genito-Urinary Drugs Market Share Forecast by Type (2021-2025)
Table 88. Global Genito-Urinary Drugs Sales Forecast by Application (2021-2025)
Table 89. Global Genito-Urinary Drugs Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Genito-Urinary Drugs Picture
Figure 2. Global Sales Market Share of Genito-Urinary Drugs by Type in 2019
Figure 3. OTC Picture
Figure 4. Rx Drugs Picture
Figure 5. Genito-Urinary Drugs Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Drugs Store Picture
Figure 8. Other Picture
Figure 9. Global Genito-Urinary Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Genito-Urinary Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Genito-Urinary Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Genito-Urinary Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Genito-Urinary Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Genito-Urinary Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Genito-Urinary Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Genito-Urinary Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Genito-Urinary Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Genito-Urinary Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Genito-Urinary Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Genito-Urinary Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Genito-Urinary Drugs Sales Market Share by Countries in 2018
Figure 46. North America Genito-Urinary Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Genito-Urinary Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Genito-Urinary Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Genito-Urinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Genito-Urinary Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Genito-Urinary Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Genito-Urinary Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Genito-Urinary Drugs Revenue Market Share by Regions 2019
Figure 62. China Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Genito-Urinary Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Genito-Urinary Drugs Sales Market Share by Countries in 2019
Figure 69. South America Genito-Urinary Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Genito-Urinary Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Genito-Urinary Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Genito-Urinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Genito-Urinary Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Genito-Urinary Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Genito-Urinary Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Genito-Urinary Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Genito-Urinary Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Genito-Urinary Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Genito-Urinary Drugs Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Genito-Urinary Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Genito-Urinary Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
泌尿器治療薬の世界市場（～2026年） Market Analysis and Insights: Global Urinary Drugs Market The global Urinary Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Urinary Drugs Scope and Market Size Urinary Drugs market is segmented by Type, and by A…- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 尿道スリングの世界市場（～2026年） Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the body's tissue or synthetic mesh to create a hammock-like fixture that wraps around the b…
- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…